Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity.
J Med Chem. 2021 Jun 10;64(11):7809-7838. doi: 10.1021/acs.jmedchem.1c00644. Epub 2021 May 27.
J Med Chem. 2021.
PMID: 34043358
Free PMC article.
Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy.
Nabergoj S, Mlinarič-Raščan I, Jakopin Ž.
Nabergoj S, et al.
Med Res Rev. 2019 Sep;39(5):1447-1484. doi: 10.1002/med.21557. Epub 2018 Dec 13.
Med Res Rev. 2019.
PMID: 30548868
Free PMC article.
Review.
Item in Clipboard
EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cells.
Nabergoj S, Markovič T, Avsec D, Gobec M, Podgornik H, Jakopin Ž, Mlinarič-Raščan I.
Nabergoj S, et al.
Biochem Pharmacol. 2021 Jan;183:114352. doi: 10.1016/j.bcp.2020.114352. Epub 2020 Dec 3.
Biochem Pharmacol. 2021.
PMID: 33278351
Free article.
Item in Clipboard
The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies.
Markovič T, Podgornik H, Avsec D, Nabergoj S, Mlinarič-Raščan I.
Markovič T, et al. Among authors: nabergoj s.
Int J Mol Sci. 2022 Jan 29;23(3):1599. doi: 10.3390/ijms23031599.
Int J Mol Sci. 2022.
PMID: 35163524
Free PMC article.
Item in Clipboard
Cite
Cite